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ABSTRACT 
The rapid removal of synaptically-released glutamate is essential to maintain fast 
excitatory chemical neurotransmission and to prevent NMDA receptors mediated 
synaptic plasticity impairments and cell death. Here, we used the rapid extracellular 
fluorescent glutamate sensor, iGluSnFR (intensity-based glutamate sensing fluorescent 
reporter), and high-speed imaging to quantify relative differences in glutamate clearance 
rates over a wide range of presynaptic activity in situ in the hippocampus, cortex, striatum 
and cerebellum of male C57/BL6NCrl mice. We found that the hippocampus was 
significantly more efficient at clearing synaptically-released glutamate. We also found 
that pharmacological inhibition of GLT-1, the brain’s most abundant glutamate 
transporter, slowed clearance rates to only ~ 20-25% of the effect induced by non-
selective transporter blockade. In all, our data reveal clear regional differences in 
glutamate dynamics following neural activity and suggest that non-GLT-1 transporters 
can make a large contribution to the rate of glutamate clearance when GLT-1 is 
dysfunctional. 
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Chapter 1 – Introduction 
              The neurotransmitter glutamate is required for rapid cellular communication, cell 
survival and many forms of synaptic plasticity. However, if too much glutamate 
accumulates in the extracellular space, it can impair synaptic plasticity and trigger 
apoptotic cell death (Danbolt 2001). Glutamate toxicity contributes to neuronal death in a 
variety of neurodegenerative diseases, including Huntington disease, Alzheimer disease 
and Amyotrophic Lateral Sclerosis (Hynd, Scott, & Dodd 2004; Milnerwood et al., 2010; 
Parsons & Raymond, 2014; Van Den Bosch, Van Damme, Bogaert, & Robberecht, 2006). 
Thus, understanding how the healthy brain efficiently clears extracellular glutamate 
during times of heightened neural activity may help us better understand disease states 
associated with glutamate toxicity. While different brain regions show dramatically 
different responses to plasticity-inducing neural activity as well as different susceptibility 
to glutamate toxicity, whether regional differences exist in glutamate clearance capacity is 
poorly understood. My study focused on the real-time extracellular glutamate dynamics in 
4 different brain regions (hippocampus, cortex, striatum and cerebellum), each of which 
receive dense glutamatergic innervation. 
 
1.1 Glutamate: the brain’s most abundant excitatory neurotransmitter 
             L-Glutamate, an amino acid, is the most abundant excitatory neurotransmitter in 
the mammalian brain. Glutamate is essential for fast excitatory neurotransmission and 
plays a key role in cognition, learning and memory (Danbolt 2001; Fonnum, 1984; O P 
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Ottersen & Storm-Mathisen, 1984). By recording the membrane potential from motor 
neurons in response to exogenous glutamate application, it was first demonstrated in the 
1950s that glutamate has an excitatory effect in the central nervous system (CNS) (Curtis, 
Lodge, & McLennan, 1979; Curtis, Phillis, & Watkins 1961). In the late 60s and early 
70s, several studies demonstrated that glutamate is synthesized in presynaptic terminals 
and that, upon physiologically-relevant stimulation patterns, can be released in 
sufficiently high amounts to exert a postsynaptic response, thereby meeting all the criteria 
of neurotransmitter (Curtis & Johnston, 1974; Fonnum, 1984). Glutamate is now 
recognized as the principal excitatory neurotransmitter in the vertebrate nervous system, 
and has been since the early 1970s (Meldrum, 2000). 
               Extracellular glutamate concentrations vary widely and can range from 
nanomolar (in the absence of neural activity) to millimolar (during neural activity) 
concentrations (Bergles & Jahr 1997; Clements, 1996; Diamond & Jahr 1997). At rest, 
dramatic differences in glutamate concentration are observed, with nerve terminal 
concentrations typically being a thousand-fold greater than in the extracellular space 
(Danbolt 2001; O. P. Ottersen, Zhang, & Walberg, 1992; O. P. Ottersen, Laake, Reichelt, 
Haun, & Torp 1996). Neural activity results in a rapid and localized increase in the 
extracellular glutamate concentration from the nanomolar to millimolar range (Dzubay & 
Jahr, 1999); the localized and transient nature of extracellular glutamate fluctuations has 
complicated experimental measurements of glutamate concentrations. For example, in 
vitro (electrophysiology) and in vivo (microdialysis or voltammetry) studies of 
extracellular glutamate concentration has shown a variance in glutamate concentration 
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ranging from 0.02–0.1μM (measured by electrophysiology; (Herman & Jahr, 2007) to 1–
30μM (measured by microdialysis and voltammetry; (Day, Pomerleau, Burmeister, 
Huettl, & Gerhardt, 2006; McLamore et al., 2010; Moussawi, Riegel, Nair, & Kalivas, 
2011; Oldenziel et al., 2007) with the majority of microdialysis measurements falling in 
the 1-5 μM range (Baker et al., 2003; Melendez, Hicks, Cagle, & Kalivas, 2005; Miele, 
Berners, Boutelle, Kusakabe, & Fillenz, 1996; Miller et al., 2008). These discrepancies 
likely reflect the transient nature of glutamate neurotransmission; localized glutamate 
concentrations can fluctuate from the nanomolar to millimolar range on a millisecond 
timescale during neural activity (Bergles & Jahr 1997). 
 
            1.1.1 Essential components of glutamatergic neurotransmission: release, 
receptor, reuptake, recycle 
            In the nerve terminal, glutamate is transported into synaptic vesicles by vesicular 
glutamate transporters (VGLUTs: VGLUT 1, VGLUT 2, VGLUT 3) (Liguz-Lecznar & 
Skangiel-Kramska, 2007;  Naito & Ueda, 1983). Glutamate is released from the 
presynaptic glutamate-containing vesicles into the extracellular space via exocytosis   
(Cousin & Robinson, 1999; Ludger & Galli, 1998). During neural activity, glutamate is 
released into the synaptic cleft, where it can bind with different classes of glutamate 
receptors. Glutamate receptors are divided into ionotropic and metabotropic subtypes, 
which can localize to both pre- and postsynaptic membranes (Backus, Kettenmann, & 
Schachner, 1989; Glaum, Holzwarth, & Miller, 1990; Grewer & Rauen, 2005; Nakanishi 
et al., 1994; Sontheimer, Kettenmann, Backus, & Schachner, 1988). Ionotropic glutamate 
receptors directly convert the chemical signal into an electrical response. In contrast, 
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metabotropic glutamate receptors act indirectly through second messenger systems which 
can exert a wide variety of downstream effects (Nakanishi et al., 1994). 
 
Ionotropic and metabotropic glutamate receptors can be further broken down                  
into different subtypes. The families of ionotropic glutamate receptor include α-amino-3-
hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) / Kainate receptors and N-methyl-D-
aspartate (NMDA) receptors. Metabotropic receptors (mGluR1-8) are subdivided into 
three groups based on sequence homology: group I (mGluR1, mGluR5), group II 
(mGluR2 and mGluR3) and group III (mGluR4, mGluR6, mGluR7, mGluR8). Group I 
mGluRs are located mainly post-synaptically and enhance neuronal excitability, whereas 
group II and III mGluRs are mainly presynaptic and inhibit neurotransmitter release 
(Niswender & Conn, 2010). AMPA receptors (AMPARs) and kainite receptors (KARs) 
can be further divided into subgroups based on their subunit composition: GluA1- GluA4 
subunits for AMPARs and GluK1- GluK5 subunits for KARs (Traynelis et al., 2010). 
 
AMPARs are heterotetrameric complexes (Song & Huganir, 2002) that assemble 
from four distinct subunits; interestingly, AMPAR subunit composition determines the 
Ca2+ permeability of the receptor (Greger, Ziff, & Penn, 2007). AMPARs are typically 
permeable to cations Na+ and K+, and Ca2+ ion flux is prevented by the presence of the 
GluA2 subunit. However, AMPARs lacking the GluA2 subunit are fully functional and 
permeable to Ca2+ (Meldrum, 2000). AMPARs have rapid activation and inactivation 
kinetics, with AMPAR-mediated excitatory postsynaptic currents (EPSCs) decaying 
within a few milliseconds (Clements, Feltz, Sahara, & Westbrook, 1998; Colquhoun, 
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Jonas, & Sakmann, 1992; Hestrin, 1992). AMPAR-mediated EPSCs represent the 
primary contributor to rapid postsynaptic current flux at a typical excitatory synapse 
(Meldrum, 2000). 
 
NMDA receptors (NMDARs) play an important role in synaptic transmission and 
neural plasticity during learning and memory due to their unique characteristics, including 
their slow activation kinetics (occurring in ~10 ms) (Dzubay & Jahr, 1996), slow 
inactivation kinetics, high permeability to Ca2+ and blockade by Mg2+ at resting 
membrane potentials. Activation of NMDARs require not only glutamate binding, but 
also the removal of the Mg2+ block by postsynaptic depolarization, as well as the binding 
of the co-agonist glycine or D-serine (Dore et al., 2017; Iacobucci & Popescu, 2017; 
Traynelis et al., 2010). In this regard, NMDARs act as “coincidence detectors” in that 
they require simultaneous presynaptic release and postsynaptic depolarization for their 
activation. NMDARs have slower activation kinetics compared to AMPARs and have a 
higher affinity for glutamate (Traynelis et al., 2010); this high affinity, in addition to the 
slow inactivation kinetics, contributes to the long duration of NMDAR-mediated EPSCs 
(Lester & Jahr, 1992). The Ca2+ permeability of NMDARs plays a crucial role in synaptic 
plasticity by activating a variety of kinases and/or phosphatases such as Ca2+/calmodulin-
dependent protein kinase II (CaMKII) and calcineurin (Song & Huganir, 2002). 
Structurally, NMDARs are heterotetramers consisting of an obligatory GluN1 subunit and 
a combination of GluN2A-D and/or GluN3A-B subunits (Traynelis et al., 2010). The 
heterogeneous composition of NMDARs is responsible for the observed diversity in 
NMDAR function including its kinetics, sensitivity to magnesium, permeability to 
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calcium, and association with various downstream signaling pathways. As an example, 
the decay time of NMDAR-mediated EPSCs can vary within a 50-fold range depending 
upon the GluN2 subunit present, with GluN1/GluN2A-containing NMDARs producing 
the fastest decay kinetics and GluN1/GluN2D-containing NMDARs producing the 
slowest decay kinetics (Paoletti, Bellone, & Zhou, 2013; Vicini et al., 1998). 
 
In addition to the NMDAR functional diversity resulting from subunit differences, 
the consequences of NMDAR activation also depend heavily on the duration and the 
subcellular localization of the activated receptor. Synaptically located NMDARs are 
predominantly GluN2A-containing, whereas perisynaptic and extrasynaptic sites are 
enriched with GluN2B-containing NMDARs (Gladding & Raymond, 2011; Hardingham 
& Bading, 2010; Parsons & Raymond, 2014). Therefore, the rate by which glutamate is 
cleared from the extracellular space following neural activity can dramatically affect 
NMDAR signaling. 
 
The spatiotemporal profile of extracellular glutamate during neural activity shapes 
the fate of NMDAR-mediated transmission. While a brief and localized change in 
glutamate concentration results in phasic NMDAR-mediated synaptic transmission, the 
sharp rise in extracellular glutamate must be cleared quickly in order to avoid excessive 
activation of extrasynaptic NMDARs. It is the responsibility of the glutamate uptake 
system to maintain the basal extracellular concentration of glutamate at a low nanomolar 
range to minimize NMDAR activity at rest (Vyklicky et al., 2014). It is essential for the 
brain to maintain a low level of tonic extracellular glutamate in order to achieve a high 
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signal-to-noise ratio during synaptic transmission, and to prevent glutamate from reaching 
excitotoxic concentrations (Danbolt 2001; Parsons & Raymond, 2014) . It has been 
postulated that the activation of GluN2A-containing NMDARs in the synaptic region 
promotes cell survival and synaptic plasticity, while the activation of GluN2B-containing 
NMDARs in the extrasynaptic region promotes synapse weakening and excitotoxic cell 
death. There are no enzymes present that can degrade extracellular glutamate; therefore, 
cellular uptake is the only mechanism that exists to remove glutamate from the 
extracellular space and prevent the over-activation of cell death-associated extrasynaptic 
NMDARs (Balcar & Johnston, 1972; Danbolt 2001). Glutamate transporters are required 
for the cellular uptake of glutamate, and therefore mediate the spatiotemporal dynamics 
of glutamatergic neurotransmission (Tzingounis & Wadiche, 2007; Y. Zhou & Danbolt, 
2014). 
 
            1.2 Glutamate transporters 
            Astrocytes play an essential role in the rapid recycling of glutamate from the 
extracellular space. Glutamate that is taken up through glutamate transporters located on 
astrocytes is recycled and then reused as a neurotransmitter in the nerve terminal, through 
a process known as the “glutamate-glutamine cycle”. In astrocytes, glutamate is 
converted into glutamine by the enzyme glutamine synthetase, and released into the 
extracellular space where it is taken up by nerve terminals and converted back to 
glutamate (Danbolt 2001; Grewer & Rauen, 2005; Y. Zhou & Danbolt, 2014). This cycle 
is crucial to the maintenance of glutamatergic neurotransmission. Therefore, transporters 
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play the dual role of maintaining low extracellular glutamate level and recycling 
glutamate. 
 
1.2.1 Glutamate transporter subtypes 
Glutamate transporters are membrane-bound proteins that are responsible for the 
cellular uptake of glutamate. In doing so, glutamate transporters play a crucial role in 
shaping the dynamics of synaptic neurotransmission on a millisecond time scale 
(Diamond & Jahr 1997). There are five known sodium-dependent glutamate transporters, 
the location of which varies greatly from one brain region to the next. The most abundant 
glutamate transporter, glutamate transporter-1 (GLT-1, SLC1A2 also known as excitatory 
amino acid transporter 2, or EAAT2), is highly expressed in astrocytes throughout the 
neuroaxis, with particularly high expression levels observed in the hippocampus and 
neocortex (Danbolt, Storm-Mathisen, & Kanner 1992; Levy, Lehre, Rolstad, & Danbolt, 
1993). The glutamate aspartate transporter (GLAST; SLC1A3 also known as excitatory 
amino acid transporter 1, or EAAT1) is also present in astrocytes throughout the CNS, 
and is particularly enriched in the cerebellum (Berger & Hediger, 1998; Ginsberg, Martin, 
& Rothstein, 1995; Lehre, Levy, Ottersen, Storm-Mathisen, & Danbolt, 1995; Rothstein, 
Van Kammen, Levey, Martin, & Kuncl 1995; Schmitt, Asan, Pü, & Kugler, 1997). Both 
GLAST/EAAT1 and GLT-1/EAAT2 are abundantly expressed in the plasma membrane 
of astrocytes, with a subcellular localization that results in a high transporter density near 
axon terminals. In contrast, excitatory amino acid transporters 3 and 4 (EAAT3 and 
EAAT4, respectively) are predominantly expressed in neuronal membranes, with little-to-
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no expression found in astrocytes (Holmseth et al., 2012; Kanai & Hediger, 1992; 
Rothstein et al. 1994; Shashidharan et al., 1997). EAAT3 (SLC1A1) is expressed in 
neurons throughout the CNS, while EAAT4 (SLC1A6) is predominantly found in 
dendritic spines in the cerebellum. Excitatory amino acid transporter 5 (EAAT5; SLC1A7) 
expression in the brain is very low and found predominantly in the retina (Dehnes et al., 
1998; Fairman, Vandenberg, Arriza, Kavanaught, & Amara, 1995).  Table 1 below 
summarizes both the cellular and regional locations of the glutamate transporter subtypes: 
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Table 1: Regional and cellular locations of the different excitatory amino acid 
transporter (EAAT) subtypes. Adapted from Yun Zhou & Danbolt, 2013 
 
 
 
 
 
Glutamate transporter Regional location Cellular location 
EAAT 1/ GLAST In all brain areas, highest in 
cerebellum 
 
Astrocytes 
EAAT2/ GLT-1 In all brain areas, highest in 
hippocampus and neocortex 
(layer I-VI) 
 
Astrocytes 
EAAT 3/ EAAC1 Throughout CNS, mainly 
hippocampus 
Neurons 
EAAT 4 Predominantly in Cerebellar 
Purkinje cells 
 
Neurons 
EAAT 5 Retina Retinal photoreceptors and 
bipolar cells 
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1.2.2 Knockout studies: uncovering the role of individual glutamate 
transporters 
 
The first glutamate transporter to be purified was GLT-1 (Danbolt, Pines, & 
Kanner 1990; Pines et al. 1992). Early studies indicated that GLT-1 is responsible for 
approximately 95% of glutamate uptake activity (Danbolt et al. 1992; Haugeto et al., 
1996), a number that is still highly-cited today. In mice, genetic deletion of the SLC1A2 
gene that encodes the GLT-1 protein confirmed an essential role for GLT-1 in 
maintaining a low concentration of extracellular glutamate and protecting the brain from 
excitotoxicity (Otis & Kavanaugh, 2000; Tanaka et al., 1997). GLT-1 deficient 
homozygous mice present with epilepsy, an increased susceptibility to acute cortical 
injury and a reduced life span. Knocking out GLAST and GLT-1 together results in 
perinatal mortality (Kiryk, Aida, Tanaka, & Banerjee, 2008; Matsugami et al., 2006; Otis 
& Kavanaugh, 2000; Tanaka et al., 1997). GLAST deficient mice exhibit impaired 
cerebellar function, resulting in poor motor coordination (Watase et al., 1998). Genetic 
deletion of EAAT3 in mice results in premature aging as determined by age dependent 
brain atrophy (cortical thinning and ventricular enlargement), and pronounced behavioral 
abnormalities including a reduction in spontaneous locomotor activity (Aoyama et al., 
2006; Lane et al., 2014; Stoffel, 1997). 
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1.2.3 Mechanism of glutamate transport 
             The glutamate transporters are commonly referred to as “high affinity 
transporters” due to their high affinity for glutamate. The Kt values for GLAST, GLT-1 
and EAAC1 ranges between 10-20 µM of glutamate (Tzingounis & Wadiche, 2007). The 
affinities for EAAT4 and EAAT5 are of higher and lower magnitude by one order, 
respectively (Arriza et al., 1994; Danbolt 2001; Fairman et al., 1995). It is important to 
note that the effective transport of glutamate during neural activity depends not only upon 
the affinity of the transporters, but also the probability of successful transport upon 
glutamate binding, the time required to complete a transport cycle (i.e. turnover rate), and 
the subcellular localization of the transporter expression with respect to the sites of 
glutamate release (Tzingounis & Wadiche, 2007; Vandenberg & Ryan, 2013; Zhou & 
Danbolt 2014). The stoichiometry of glutamate transport couples the co-transport of one 
glutamate molecule with three Na+ ions and one H+  ion from outside to inside the cell, 
with the movement of one K+ ion from inside to outside of the cell (Figure 1) (Zhou & 
Danbolt 2013). In addition, EAAT4 and EAAT5 exhibit a non stoichiometrically-coupled 
glutamate-gated Cl- current conductance, thereby acting as an extracellular glutamate 
sensor that can induce cellular hyperpolarization (Fairman et al. 1995; Melzer, Torres-
Salazar, & Fahlke, 2005; Veruki, Mørkve, & Hartveit, 2006; Wadiche, Amara, & 
Kavanaugh, 1995). 
 
Glutamate transporters are homomers composed of three independent subunits 
(homotrimers) in the shape of a bowl, with the glutamate binding site located towards the 
bottom of the bowl and in between two hairpin loops of gates to the glutamate binding 
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site (Grewer & Rauen, 2005; Tzingounis & Wadiche, 2007; Yernool, Boudker, Jin, & 
Gouaux, 2004). Glutamate transporters have two major conformations: an outward 
conformation with the glutamate binding site exposed to the extracellular space, and an 
inward conformation with the glutamate binding domain exposed to the cytoplasm. When 
glutamate and co-transported ions sequentially bind with the outward conformation, it 
leads to translocation of the amino acid to the inside, whereas binding of an intracellular 
K+ ion to the inward conformation leads to the reorientation of the glutamate binding site, 
back to the outward state. 
 
1.2.4 Developmental regulation of glutamate transporters 
The contribution of glutamate transporters to the rate of glutamate clearance from 
the extracellular space gradually increases with development. Low glial transporter 
expression results in slow transporter-mediated uptake in the neonatal rat brain in the first 
week of life. As neural circuitry matures, transporter expression increases and reaches 
adult levels by about one month of age (Schmidt, Wolf, & Republic, 1988; Thomas, Tian, 
& Diamond 2011; Ullensvang, Lehre, & Danbolt, 1997). Interestingly, in the rat brain, 
GLAST expression is initially higher than GLT-1 during early postnatal development, but 
the density of GLT-1 rapidly increases and by one month of age, GLT-1 becomes the 
predominant glutamate transporter in the CNS (Christensen & Fonnum, 1992; Kish, Kim, 
& Ueda, 1989; Matsugami et al., 2006; Ullensvang et al., 1997). 
While the aforementioned developmental studies were largely conducted in the 
hippocampus, the early increase in glutamate transporter expression is also readily 
observed in additional brain regions. Electrophysiological recordings of synaptically-
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activated transporter currents (STCs) demonstrate that that the efficiency of glutamate 
uptake increases with age in both the hippocampus and cortex (Hanson et al., 2015). 
 
1.3 Role of diffusion in glutamate clearance 
             Following neural activity and the synaptic release of glutamate, in addition to 
transporter-mediated uptake, the extracellular concentration of glutamate at a given 
location can also be reduced by passive diffusion. Therefore, overall extracellular 
glutamate dynamics will depend on the transporter localization and density, as well as the 
geometry and barriers present in the local extracellular microenvironment (Sarantis et al., 
1993).  
            Diffusion rate is dependent upon the structure of the extracellular space. The two 
factors that affect the extracellular diffusion rate are volume fraction and tortuosity 
(Nicholson & Sykova, 1998). Tortuosity refers to barriers to diffusion and is quantified 
by comparing diffusion in the sample of interest to the diffusion of the same substance in 
a free medium. Volume fraction simply refers to the volume of extracellular (void) space 
(Nicholson & Sykova, 1998). The geometry of the extracellular matrix, largely shaped by 
glial cells, contributes to the tortuosity (Nicholson, Kamali-Zare, & Tao 2011). Methods 
such as real-time iontophoresis and integrative optical imaging have shown, not 
surprisingly, that narrow and tortuous space slows diffusion across the extracellular space 
(Nicholson & Tao, 1993; Syková, Nicholson, & Sykova, Eva; Nicholson, 2008). 
Interestingly, electron microscopy studies have demonstrated that as glutamate transporter 
expression increases during development, the volume of the extracellular decreases, 
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resulting in a shift from fast diffusion and slow uptake in the neonate brain, to slow 
diffusion and rapid uptake in the adult brain (Thomas et al. 2011). The contribution of 
diffusion to glutamate clearance cannot be measured by the biochemical uptake assay, 
and it has been difficult to ascertain how much diffusion contributes to the kinetics of the 
STC. 
 
1.4.1 Quantifying the efficiency of glutamate uptake with the biochemical uptake 
assay 
            Soon after glutamate was identified as the primary excitatory neurotransmitter in 
the CNS, it was recognized that novel methods would be required to study how the spatial 
and temporal dynamics of this essential signaling molecule were regulated. Several 
technological approaches were established to quantify the efficiency of high-affinity 
glutamate uptake. Among them, the biochemical uptake assay has dramatically increased 
out understanding of the glutamate transporter system, and is still in heavy use today 
(Currie & Kelly, 1981; Danbolt, Furness, & Zhou 2016). 
 
The biochemical uptake assay is often performed in neuronal and/or astrocyte 
cultures from different brain regions (such as hippocampus, cortex, striatum, cerebellum) 
(Horak, Nashner, & Diener, 1990) or using synaptosomal preparations (pinched off 
nerve-endings; Danbolt et al. 2016; Dodd et al., 1981; Morgan, 1971; Raiteri & Raiteri, 
2000). In this assay, the culture medium or the synaptosome homogenate is incubated in a 
known concentration of exogenous, radio-labeled glutamate for several minutes. Liquid 
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scintillation is then used to quantify the glutamate uptake capacity of the preparation 
(Levi & Raiteri, 1973). Although this biochemical assay is a commonly used preparation 
that is still widely used today, it is associated with some important caveats. While the 
majority of glutamate transporters are expressed on astrocyte membranes, so-called 
“pure” synaptosomal preparations should contain little-to-no astrocytes, and the purity of 
a synaptosome preparation is likely to vary greatly from one lab to another. Indeed, a 
recent study demonstrated that the biochemical uptake assay grossly overemphasizes the 
contribution of neuronal uptake to total glutamate transport (Petr et al., 2015). In addition, 
the biochemical assay is unable to mimic the physiological properties of synaptic release, 
and is devoid of any tripartite synaptic structure, factors that undoubtedly contribute to 
the extracellular profile of glutamate transients (Danbolt et al. 2016). Overall, 
biochemical assays lack the representation of physiological glutamate dynamics in situ, 
and it has been suggested that glutamate uptake should be studied in situ wherever 
possible (Danbolt et al. 2016; Danbolt 2001; Petr et al., 2015). 
 
1.4.2 Quantifying the efficiency of glutamate uptake with electrophysiological 
measures of transporter currents 
To increase our fundamental understanding of glutamate transport, it is necessary 
to quantify the clearance rates of endogenous glutamate in situ following synaptic 
activity. Glutamate transport is an electrogenic process; there is net influx of positive 
charge associated with each transport cycle (Brew & Attwell, 1987; Schwartz & 
Tachibana, 1990; Wyllie, Mathie, Symonds, & Cull‐ Candy, 1991). The electrogenic 
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nature of glutamate uptake enables its quantification using whole-cell electrophysiology. 
By measuring this electrogenic transporter current in astrocytes via patch-clamp 
recording, it is possible to determine the contribution of glutamate transporters to the 
clearance of synaptically-released glutamate. Interestingly, while STCs are typically 
measured in astrocytes (Bergles & Jahr 1997) they have also been observed in neurons 
(Otis, Kavanaugh, & Jahr, 1997 1997), reflecting the expression of glutamate transporters 
on both cell types. However, STC measurements are almost always made from astrocytes 
because of the high density of glutamate transporters on astrocyte membranes. STC in 
glial cells has been measured in culture (Linden, 1997), and acute slices from different 
brain regions including the cerebellum (Clark & Barbour, 1997), hippocampus (Bergles 
& Jahr 1997), cortex (Armbruster, Hampton, Yang, & Dulla, 2014; Armbruster, Hanson, 
& Dulla, 2016; Hanson et al., 2015) and striatum (Parsons et al., 2016). Nonetheless, STC 
recordings are technically demanding, are extremely difficult to elicit in brain regions 
with relatively weak glutamatergic afferent connectivity, and are restricted to the 
glutamate profile occurring at a single astrocyte. Furthermore, using STCs to understand 
how extracellular glutamate profiles are influenced by transporter dysfunction is 
complicated by the fact that transporter inhibition/dysfunction will reduce the size of the 
STC itself to undetectable levels. 
            1.4.3 Using novel iGluSnFR technique to revisit extracellular glutamate 
dynamics 
Despite the extremely organized morphology of tripartite synaptic structure 
(Perea, Navarrete, & Araque, 2009), with the exception of electrophysiological recordings 
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of STCs, the large majority of our knowledge of glutamate transporter function has been 
derived from biochemical uptake assays in homogenized tissue preparations. While it is 
widely accepted that astrocytes mediate the bulk of glutamate uptake in the brain, the 
biochemical uptake assay was recently shown to dramatically overemphasize neuronal 
uptake at the expense of astrocytic uptake, highlighting the need to study glutamate 
dynamics and glutamate transporter function in situ (Petr et al., 2015). Optogenetics 
provides us with a relatively new biosensor to study glutamate dynamics, allowing for the 
real-time visualization and quantification of glutamate dynamics in situ. The extracellular 
glutamate sensor called iGluSnFR (intensity based glutamate sensing fluorescent 
reporter) opened a new window to study glutamate dynamics in real-time (Marvin et al., 
2013). iGluSnFR is a circular GFP molecule which is fused to an extracellular glutamate 
binding site. When glutamate is not bound with the iGluSnFR, the GFP fluoresces at a 
low intensity. When glutamate binds with iGluSnFR, it causes conformational changes in 
the iGluSnFR molecule and the GFP intensity increases. The whole process occurs on a  
millisecond time scale and is highly selective to extracellular glutamate. These features 
make iGluSnFR a perfect candidate to measure glutamate clearance in situ. In this thesis, 
I use iGluSnFR to understand how glutamate dynamics are influenced by different brain 
regions and in response to varying degrees of neural activity.  
           1.5 Hypothesis 
Glutamate clearances rates vary in both a region- and activity-dependent manner; 
thus, glutamate uptake should be studied in real-time, in situ and in response to 
endogenous glutamate release during neural activity.  
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1.6 Aims of the thesis project 
 Use iGluSnFR to visualize, in real-time, the spatiotemporal 
extracellular dynamics of synaptically-released glutamate over a wide 
range of presynaptic activity in the hippocampus, cortex, striatum and 
cerebellum. 
 Use a pharmacological approach to quantify the contribution of GLT-1 
and non-GLT-1 glutamate transporters to the overall clearance rates of 
synaptically-released glutamate in hippocampus, cortex, striatum and 
cerebellum. 
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Chapter 2: Materials and Methods 
 
2.1 Animals 
All experiments were performed on acute brain slices obtained from male C57BL/6NCrl 
mice. Mice were ordered from Charles River at ~3–4 weeks of age and were provided 
with a minimum of 2 d of acclimatization upon arriving at Memorial University’s animal 
care facility. Mice were group housed in ventilated cage racks, were provided with 
standard chow and water ad libitum, and were maintained on a normal 12 hours light/dark 
cycle. All experimental procedures were approved by Memorial University’s Institutional 
Animal Care Committee and were performed in accordance with the guidelines set by the 
Canadian Council on Animal Care. 
 
2.2 Stereotaxic surgery 
Male C57BL/6NCrl mice (4–6 weeks of age) were anesthetized by isoflurane inhalation 
(3%) and maintained with 1.5–2% isoflurane for the duration of the surgical procedure. 
Mice were placed on a heating pad to maintain body temperature throughout the surgery 
and secured within the ear bars of a standard stereotaxic apparatus (Stoelting). Eye drops 
were used to lubricate the eyes throughout the procedure, and a subcutaneous 0.5 ml 
injection of 0.9% sterile saline was provided to help prevent dehydration. When 
unresponsive to toe-pinch, a small amount of fur above the scalp was cut with a pair of 
scissors, and a 0.1 ml bolus of 0.2% lidocaine was injected below the scalp. A small 
incision was then made in the scalp around bregma, and the underlying skull was 
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exposed. A hand drill was used to carefully thin the skull at the desired coordinates from 
bregma, and a fine bent needle tip was used to peel back the last layer of skull to expose 
the underlying cortex while minimizing tissue damage. A Neuros 7002 Hamilton syringe 
was attached to an infusion pump (Pump 11 Elite Nanomite; Harvard Apparatus, 
Massachusetts, United States), which was then secured to the stereotaxic frame. A total 
volume of 1 µl of AAV1.hSyn. iGluSnFr.WPRE.SV40 (synapsin-iGluSnFR; Penn Vector 
Core, catalog #AV-1-PV2723; kindly provided by Dr. Loren L. Looger and Janelia 
Research Campus of the Howard Hughes Medical Institute, Ashburn, VA) was injected 
into the hippocampus, cortex, striatum or cerebellum at an injection rate of 2 nl/s. The 
syringe was left in place for an additional 5 min after the injection. The following 
coordinates were used with respect to bregma: hippocampus, 2.6 mm posterior, 2.4 mm 
lateral (right), 1.9 mm ventral to brain surface; cortex, 0.7 mm anterior, 2.0 mm lateral 
(right), 0.6 mm ventral; striatum, 0.7 mm anterior, 2.0 mm lateral (right), 2.6 mm ventral; 
cerebellum- 2.6 mm posterior, 2.00 mm right lateral, 1.00 mm ventral to brain surface. 
The syringe was slowly withdrawn, the incision was sutured, and mice were given a 
subcutaneous injection of 0.5 ml of 0.9% saline containing 2 mg/kg meloxicam before 
being placed on a heating pad for ~30 min to accelerate recovery. 
 
2.3 Slice preparation 
At 2–3 months of age (3–6 weeks after iGluSnFR injection to ensure proper expression of 
the virus within the injected brain region), mice were anesthetized with isoflurane and 
decapitated, and the brain was quickly removed and immersed in ice-cold oxygenated 
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(95% O2/5% CO2) slicing solution consisting of (in mM) 125 NaCl, 2.5 KCl, 25 
NaHCO3, 1.25 NaH2PO4, 2.5 MgCl2, 0.5 CaCl2, and 10 glucose. 
 
Coronal brain slices (350 µm) containing the hippocampus, striatum, cortex or 
cerebellum were obtained with a Lecia VT1000 Vibratome (Greenville, USA). Slices 
were then placed in artificial cerebrospinal fluid (ACSF) containing (in mM) 125 NaCl, 
2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, and 10 glucose. Slices were 
recovered in oxygenated ACSF for 45 min at room temperature before experimentation. 
 
2.4 Imaging and image analysis 
Slices were then transferred to the recording chamber, and a peristaltic pump (MP-II; 
Harvard Apparatus) was used to perfuse oxygenated ACSF at a flow rate of 2 ml/min. 
ACSF was heated to 32°C using an in-line heater and temperature controller (TC- 344C; 
Harvard Apparatus). Glass stimulating electrodes were pulled using a Narishige PB-7 
pipette puller to a resistance of 1–3MΩ when filled with ACSF. For hippocampal 
sections, the stimulating electrode was placed directly in the Schaffer collateral pathway 
within the stratum radiatum. For cortical sections, the stimulating electrode was placed in 
the deep layers of the somatosensory cortex. For striatal sections, the stimulation 
electrode was placed in the dorsal striatum. For the cerebellar slices, the glass electrodes 
were placed in the molecular layers of the cerebellum. In all cases, the stimulating 
electrode was placed at a depth ~50–100 µm below the slice surface. Clampex software 
(Molecular Devices, San Jose, California, USA) was used to send TTL triggers through 
the digital outputs of a Digidata 1550A (Molecular Devices) for precise control over an 
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LED illumination source (Prior, Lumen 300), an EM-CCD camera (Andor, iXon Ultra 
897), and an Iso-flex stimulus isolator (AMPI). A basal, unstimulated iGluSnFR 
expression level was first measured in each slice using a constant LED power and 
exposure time. iGluSnFR responses to evoked neural activity were recorded with Andor 
Solis software, using 4 x 4 binning and an acquisition rate of 205 frames per second. 
Evoked iGluSnFR responses were averaged over three to five trials, with nonstimulus 
trials interleaved to control for any bleaching of the iGluSnFR signal during acquisition. 
The nonstimulus trials were averaged in ImageJ (https://imagej.nih.gov/ij/ ) and 
subtracted from the average of the stimulus trials using the IOS and VSD signal processor 
plugin. The dynamics of extracellular glutamate within a given field were determined by 
calculating the average fluorescence intensity within a 10 x 10 pixel ROI (1 pixel at 4 x 4 
binning = 15.6 µm) placed adjacent to the location of the stimulating electrode. Values 
for % ΔF/F were copied to GraphPad Prism (GraphPad Software, 7825 Fay Avenue, 
Suite 230, La Jolla, CA 92037 USA), where decay tau was calculated from the response 
peak (in the case of short bursts of activity) or the end of stimulation (in the case of longer 
high-frequency trains) using a single exponential nonlinear curve fit. To visually 
represent the time course of the response, I applied the “fire” heat map in ImageJ and 
used the “volume viewer” 3D plugin to display the response along the z (time) axis. 
 
2.5 Pharmacology 
All the drugs used for these experiments were from Tocris Bioscience (Bristol, United 
Kigdom). Drugs used in the study and their concentrations are as follows: dihydrokainic 
acid (DHK) (catalog # 0111), a competitive and selective GLT-1 blocker (EAAT-2; 300 
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µM); DL-threo-β-benzyloxyaspartic acid (DL-TBOA) (catalog #1223), a competitive and 
nonselective excitatory amino acid transporter blocker (10 and 100 µM); DNQX 
disodium salt (catalog # 231210), an AMPA/kainite receptor antagonist (20 µM); and D-
AP-5(catalog#0106), a selective NMDA receptor antagonist (50 µM). 
 
2.6 Experimental design and statistics 
The statistical tests used included one-way ANOVA, one-way repeated-measures (RM) 
ANOVA, two-way ANOVA, two-way RM ANOVA, and linear regression. Post hoc tests 
included Tukey’s, Bonferroni’s, and Dunnett’s tests. The statistical test used for each 
experiment is indicated in Results. P values of <0.05 were considered significant. Where 
indicated, N and n refer to the number of animals and slices used in each experiment, 
respectively. 
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Chapter 3 - Results 
 
3.1 Characterization of glutamate dynamics in different brain regions 
            3.1.1 Extracellular glutamate dynamics in the hippocampus 
The hippocampus has dense glutamatergic connections, many of which exhibit 
robust activity-dependent synaptic plasticity. The Schaffer collateral pathway, consisting 
of axons from the CA3 hippocampal sub-region that synapse onto CA1 dendrites in the 
stratum radiatum (Fig 2), is one of the most-commonly studied synaptic connections in 
the mammalian brain. I first examined activity-dependent regulation of extracellular 
glutamate dynamics within hippocampal circuitry by stimulating glutamate release at the 
CA3-CA1 synapse with a glass electrode placed in the Schaffer collateral pathway of 
iGluSnFR-injected mice (Fig 3A). iGluSnFR was expressed under the control of the 
neuron-specific synaptic promoter. Thus, the fluorescent signals quantified in the present 
study represent relative differences in the amount and time-course of synaptically-
released glutamate sensed at the extracellular neuronal surface. The iGluSnFR reporter 
consists of a circularly-permuted GFP molecule fused to a glutamate binding domain. 
Upon glutamate binding, a conformational change increases the fluorescence intensity of 
GFP emission (Marvin et al., 2013). Therefore, the increase in fluorescent intensity can 
be used to quantify relative changes in the amount of glutamate released and the time to 
clear synaptically-released glutamate from the extracellular space following various 
patterns of presynaptic activity. Glutamate release and clearance rates were visualized in 
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real-time by high-speed widefield imaging (205 frames per second) of iGluSnFR 
transients in response to afferent stimulation of short bursts of activity (2, 5 and 10 pulses 
at 100 Hz) and longer trains of high frequency stimulation (HFS; 50 and 100 pulses at 
100 Hz). The relative magnitude of glutamate release was measured by the peak 
iGluSnFR response (Fig 3B, 3D) and the clearance rate was measured by calculating the 
iGluSnFR decay tau immediately following the termination of the stimulation period (Fig 
3C, 3E), as described previously (Armbruster et al., 2016; Parsons et al., 2016). Not 
surprisingly, I found that increasing the number of pulses within the shorter bursts 
dramatically increased iGluSnFR peaks (Fig 3D, N=10, n=17, RM-ANOVA, p<0.001), 
with %ΔF/F values more than doubling as afferent stimulation increased from 2 to 10 
pulses at 100 Hz. In contrast, glutamate clearance rates were comparatively stable over 
this stimulation range (Fig 3E) despite the clear increase in response size. When longer 
trains of HFS were employed, including 50 and 100 pulses at 100 Hz, glutamate clearance 
rates slowed over three-fold (Fig 3E, N=10, n=17, RM-ANOVA, p<0.001). Within a 
given stimulation paradigm, I did not find any significant correlation between the peak 
(i.e. largest amount of glutamate accumulation reached) and the decay tau (i.e. glutamate 
clearance rate) both for short bursts (Fig 4A) and longer trains of HFS (Fig 4B). These 
data demonstrate that glutamate clearance rates are more closely linked to the duration of 
presynaptic activity (i.e. short bursts vs. longer trains of HFS) than the amount of 
glutamate released. 
To account for the number of axons recruited during electrical stimulation, I 
varied the stimulation intensity from 25 to 250 µA while holding the stimulation duration 
constant (5 pulses at 100 Hz; Fig. 5). Not surprisingly, increasing the stimulus intensity 
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resulted in larger iGluSnFR responses in the hippocampus (Fig. 5; N =4, n = 7). Stimulus 
intensity also had a small but consistent and significant effect on iGluSnFR decay tau; 
however, iGluSnFR response peaks were much more sensitive than decay to increasing 
stimulus strengths (Fig. 5B–D; N = 4, n = 7; two-way RM ANOVA; stimulus 
intensity, p < 0.001; peak vs decay, p <0.001; interaction, p<0.001). Therefore, recruiting 
more glutamate afferents with larger stimulus intensities dramatically enhances the size of 
the iGluSnFR response but has a relatively limited effect on decay kinetics. These data 
support the idea that clearance rates are more heavily influenced by the duration of 
afferent activity than the magnitude of release. 
 
3.1.2 Extracellular glutamate dynamics in cortex 
            I repeated the above experiments in cortex as it has been widely studied brain area 
containing dense glutamatergic afferents. In the cortex (Fig. 6A), increasing the number 
of pulses dramatically increased the response size of iGluSnFR transients, in line with my 
expectations and my results obtained in the hippocampus (Fig. 6B, D; N =8, n = 11, RM 
ANOVA, p <0.001). During short bursts of presynaptic activity, the mean decay tau 
increased from 2 to 10 pulses, although post hoc significance was only observed when 
longer trains of HFS were applied (Fig. 6C, E; N =8, n =11, RM ANOVA, p < 0.001). In 
response to short bursts of activity, there was no significant correlation between 
iGluSnFR %ΔF/F (peak) and decay measurements (Fig. 7A) as seen in the hippocampus; 
however, a strong association was observed following HFS protocols in the cortex (Fig. 
7B), with larger responses taking longer to clear from the extracellular space. 
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To account for the number of axons recruited during electrical stimulation, I varied the 
stimulation intensity from 25 to 250 µA while holding the stimulation duration constant 
(5 pulses at 100 Hz; Fig. 8). Stimulus intensity also had a small but consistent and 
significant effect on iGluSnFR decay tau; however, iGluSnFR response peaks were much 
more sensitive than decay to increasing stimulus strengths, as seen in hippocampus (Fig. 
8B–D; N = 4, n = 9; two-way RM ANOVA; stimulus intensity, p < 0.001; peak vs decay, 
p <0.001; interaction, p<0.001). Therefore, recruiting more glutamate afferents with 
larger stimulus intensities dramatically enhances the size of the iGluSnFR response but 
has a relatively limited effect on decay kinetics. 
 
3.1.3 Extracellular glutamate dynamics in striatum 
            I repeated the above experiments in dorsal striatum (Fig. 9A). Again, the amount 
of evoked glutamate release was also highly sensitive to the number of pulses of afferent 
stimulation, as expected (Fig. 9 B, D; N= 4, n = 8, RM ANOVA, p < 0.001). The mean 
clearance rate increased as burst size increased from 2 to 10 pulses, but again, post hoc 
significance was only observed after longer trains of HFS (Fig. 9C, E; N =4, n = 8, RM 
ANOVA, p < 0.001), similar to my observations in the cortex. Within a given stimulation 
paradigm, I observed no significant correlation between iGluSnFR %ΔF/F and decay taus 
for short bursts (Fig. 10A) or longer trains of HFS (Fig. 10B), suggesting that like the 
hippocampus, striatal clearance rates are more dependent on the duration of presynaptic 
activity than the amount of glutamate release per se. 
To account for the number of axons recruited during electrical stimulation, I varied the 
stimulation intensity from 25 to 250 µA while holding the stimulation duration constant 
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(5 pulses at 100 Hz; Fig. 11). Not surprisingly, increasing the stimulus intensity resulted 
in larger iGluSnFR responses in the striatum (Fig. 11; N =5, n = 11); stimulus intensity 
also had a small but consistent and significant effect on iGluSnFR decay tau; however, 
iGluSnFR response peaks were much more sensitive than decay to increasing stimulus 
strengths (Fig. 11B–D; N = 5, n = 11; two-way RM ANOVA; stimulus intensity, p < 
0.001; peak vs decay, p <0.001; interaction, p<0.001). Therefore, recruiting more 
glutamate afferents with larger stimulus intensities dramatically enhances the size of the 
iGluSnFR response but has a relatively limited effect on decay kinetics. These data 
support the idea that clearance rates are more heavily influenced by the duration of 
afferent activity than the magnitude of release. 
 
3.1.4 Extracellular glutamate dynamics in cerebellum 
Lastly, I repeated the same experiment in the molecular layers of the cerebellum 
(12A). I was particularly interested in the cerebellum due to the transporter expression 
profile in this region, which is dominated by GLAST instead of GLT-1 (Zhou & Danbolt 
2013). The amount of evoked glutamate release was also highly sensitive to the number 
of pulses of afferent stimulation, as expected (Fig. 12 B, D; N= 3, n = 9, RM ANOVA, p 
< 0.001). The mean clearance rate increased as burst size increased from 2 to 10 pulses, 
but again, post hoc significance was only observed after longer trains of HFS (Fig. 12C, 
E; N =3, n = 9, RM ANOVA, p < 0.001), similar to my observations in the cortex. Within 
a given stimulation paradigm, I observed no significant correlation between iGluSnFR 
%ΔF/F and decay taus for short bursts (Fig. 13A) or longer trains of HFS (Fig. 13B), 
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suggesting that like the hippocampus, cerebellar clearance rates are more dependent on 
the duration of presynaptic activity than the amount of glutamate release. 
 
3.1.5 Comparison of extracellular glutamate dynamics between different brain 
regions 
Although the general relationships between presynaptic activity and clearance rate 
appeared to be similar for the hippocampus, cortex, striatum and cerebellum, interesting 
regional differences were revealed when I directly compared glutamate clearance rates in 
the four regions in response to shorter bursts of presynaptic activity and longer trains of 
HFS (Fig. 14 A-C, 10 pulse data shown for representation), (Fig 15, A, B). The data reveal 
that, both for shorter bursts (2, 5, 10 pulses at 100 Hz) and longer trains of HFS (50, 100 
pulses at 100 Hz), the hippocampus exhibited the fastest mean clearance rates, while the 
striatum and particulalry the cerebellum showed the slowest mean clearance rates (Fig. 15 
A; Two way RM- ANOVA brain region p<0.001, number of pulses p<0.001, interaction 
p<0.001; hippocampus N=10, n=7, cortex N=8, n=11, striatum N=4, n=8, cerebellum 
N=3, n=9). 
Longer trains of HFS also revealed clear regional effects, with the hippocampus 
clearing glutamate the fastest and the cerebellum clearing glutamate the slowest (Fig. 
15B, Two-Way RM-ANOVA, brain region p<0.001, number of pulses p<0.001, 
interaction p=0.71, hippocampus N=10, n=7, cortex N=8, n=11, striatum N=4, n=8, 
cerebellum N=3, n=9). In all, these data reveal clear regional and activity-dependent 
effects on glutamate clearance rates and highlight the need to study glutamate dynamics 
in situ and in response to synaptic activity. 
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As no mechanism exists to degrade glutamate from the extracellular space, the rate of 
glutamate clearance from its release site is dependent on both diffusion and transporter-
mediated uptake. For example, the fast clearance rates observed in the hippocampus could 
be driven primarily by a fast diffusion rate or highly efficient transporter-mediated 
uptake. Here, I measured the relative rate of glutamate diffusion in hippocampus, cortex, 
striatum and cerebellum by stimulating glutamate release as before, but in the presence of 
a saturating concentration of TBOA (100 µM) (Diamond 2005), a non-selective 
glutamate transporter blocker. To prevent the potential excitotoxic effect of complete 
transporter blockade, I added both d-APV (50 μM; to block NMDAR) and DNQX (20 
μM; to block AMPAR and kainite receptors) (Armbruster et al., 2016) to the bath. 
Glutamate receptor blockers alone have no effect on iGluSnFR profiles (Parsons et al., 
2016). I saw significant regional differences among the four different brain regions for 
both the shorter bursts of activity  (Figure 16A, hippocampus N=3, n=7, cortex N=4, n=6, 
striatum N=5, n=9, cerebellum N=3, n=9,  RM Two Way ANOVA, number of pulses 
p<0.001, brain region p<0.001, interaction p=0.017) and longer trains of HFS (16B, 
hippocampus N=3, n=7, cortex N=4, n=6, striatum N=5, n=9, cerebellum N=3, n=9, RM 
Two Way ANOVA, number of pulses p=0.1819, brain region p=0.2535, interaction 
p=0.4306). Surprisingly, the cerebellum exhibited the fastest mean diffusion rates. This 
result is suggestive of a low capacity of transporter-mediated uptake in the cerebellum, 
and that the main contributor to glutamate clearance in this region is diffusion. 
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3.2. Role of glutamate transporters in glutamate clearance 
 
                 3.2.1 Comparative role of Glutamate transporters in hippocampus 
                 Prior work used a pharmacological approach to quantify the functional 
contribution of GLT-1 relative to other excitatory amino acid transporters by measuring 
STCs before and after bath application of a saturating concentration of DHK (300 µM) 
(Diamond and Jahr 2000). The authors calculated a decay ratio, simply defined as the 
STC decay tau after transporter inhibition divided by the decay tau before transporter 
inhibition, and determined that the GLT-1 contribution to total uptake was greater in the 
hippocampus compared with the cortex, but only in the first postnatal week (Hanson et 
al., 2015). Here, I applied the same approach to the iGluSnFR transients to calculate a 
DHK (300 µM) decay ratio, representing the relative contribution of GLT-1 transporters 
to overall clearance kinetics, and also calculated a TBOA (100 µM) decay ratio, 
representing the relative contribution of all transporters to overall clearance kinetics. Note 
that the latter is not possible with STC recordings, as the STC is completely inhibited by 
this concentration of TBOA. In the hippocampus (Fig. 17), blocking GLT-1 resulted in an 
approximate twofold increase in both the size of evoked iGluSnFR responses (Fig. 17A, 
B, D) as well as the time to clear, regardless of the amount of presynaptic activity (Fig. 
17A, C, E). The observed twofold increase in clearance rates after GLT-1 inhibition is 
similar to the decay ratio observed previously for STCs (Hanson et al., 2015). 
Interestingly, when I applied TBOA (100 µM) to block all transporter-mediated uptake, 
decay ratios were approximately fivefold larger than the decay ratios observed after DHK 
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treatment (Fig. 17E; N =3, n =6; two-way RM ANOVA; treatment, p < 0.001; number of 
pulses, p =0.397; interaction, p =0.632), and TBOA had a slight but significant effect on 
increasing the size of the responses (peak) relative to DHK (Fig. 17D; N = 3, n = 6; two-
way RM ANOVA; treatment, p =0.037; number of pulses, p =0.616; interaction, p = 
0.698). For decay ratios, significant post hoc differences between the DHK and TBOA 
effects were observed for each stimulation paradigm tested (Fig. 17E; p < 0.001, 
Bonferroni’s). The dramatic difference between the decay ratio obtained in TBOA 
compared with DHK indicates either that non-GLT-1 transporters can contribute 
substantially to uptake capacity when GLT-1 is dysfunctional or that GLT-1 plays much 
less of a role in glutamate uptake than previously thought. To address the latter 
possibility, I compared the effect of saturating DHK (300 µM) with a sub-saturating 
concentration of TBOA (10µM) previously shown to have the same effect as 300 µM 
DHK on STCs in the hippocampus (Diamond 2005). It was reasoned that if GLT-1 plays 
only a minor role in overall glutamate clearance, 10µM TBOA, a sub-saturating  
concentration (Diamond 2005), should have a greater effect than 300 µM DHK on 
iGluSnFR decay kinetics. I found that the decay ratio was not significantly different 
between 10 µM TBOA and 300 µM DHK (Fig. 18B; DHK, N=3, n=4; TBOA, N=4, n=6; 
two-way RM ANOVA, p>0.05), arguing against the interpretation that GLT-1 plays only 
a minor role in glutamate clearance. In all, my pharmacological data indicate that non-
GLT-1 transporters contribute substantially to uptake capacity when GLT-1 is 
dysfunctional. 
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3.2.2 Comparative role of Glutamate transporters in cortex 
            I conducted the same experiments in cortex to determine the effect of DHK (300 
µM) and TBOA (100 µM). I found a significant difference in peak response between 
DHK and TBOA (Figure 19B, D, N=5, n=7, RM Two Way ANOVA, treatment p<0.001, 
number of pulses p=0.858, interaction p=0.999) regardless of the amount of presynaptic 
activity. Despite the larger peak responses after DHK application, I again found that 
TBOA had a much more profound effect on glutamate clearance, with DHK only slowing 
clearance rates to a fraction of the effect observed after TBOA (Figure 19 A, C, E, N=5, 
n=7, RM Two Way ANOVA, treatment p<0.001, # of pulses p=0.147, interaction 
p=0.451). 
 
I also compared the role of 10µM TBOA with 300µM DHK. I found that the 
decay ratio was not significantly different between 10 µM TBOA and 300 µM DHK (Fig. 
20B; DHK, N=4, n=6; TBOA, N=3, n=4; two-way RM ANOVA, p>0.05). In all, my 
pharmacological data indicate that non-GLT-1 transporters contribute substantially to 
uptake capacity when GLT-1 is dysfunctional in the cortex. 
 
 
 
 
 
 
 
35 
 
3.2.3 Comparative role of Glutamate transporters in striatum 
            In the striatum, DHK and TBOA also had different effects on the amount of 
extracellular glutamate accumulation, with DHK facilitating extracellular glutamate 
accumulation and TBOA returning iGluSnFR peaks to control or lower than control 
values (Fig. 21A, B, D; N= 6, n =11, two-way RM ANOVA; treatment, p < 0.001; 
number of pulses, p = 0.232; interaction, p = 0.040). The significant interaction effect 
reflects the tendency for TBOA to suppress evoked glutamate release primarily at lower 
stimulus durations (Fig. 21D). Regardless of the peak response, I again found that DHK 
had a relatively small effect on clearance rates when compared with the effect of TBOA 
(Fig. 21 A, C, E; N =6, n =11, two-way RM ANOVA; treatment, p <0.001; number of 
pulses, p = 0.105; interaction, p =0.379), similar to the results obtained in the 
hippocampus and cortex. Together, these data suggest a complex 
effect of transporter dysfunction on activity-dependent glutamate release and that a 
saturating concentration of the GLT-1 blocker DHK only slows glutamate clearance to 
~20 – 25% of that induced by nonselective transporter blockade with TBOA. 
 
I also compared the role of 10 µM TBOA with 300 µM DHK in the striatum. I 
found that the decay ratio was not significantly different between 10 µM TBOA and 300 
µM DHK (Fig. 22B; DHK, N=4, n=5; TBOA, N=3, n=6; two-way RM ANOVA, p>0.05). 
In all, my pharmacological data indicate that non-GLT-1 transporters contribute 
substantially to uptake capacity when GLT-1 is dysfunctional in striatum. 
 
 
36 
 
3.2.4 Comparative role of Glutamate transporters in cerebellum 
In the cerebellum, DHK and TBOA had different effects on the total extracellular 
glutamate concentration which I measured as the peaks. I found that, unlike other brain 
regions, DHK (300 µM) did not increase the peak iGluSnFR response. TBOA increased 
extracellular glutamate accumulation but only for short bursts of activity with 2 pulses 
(Fig. 23B, D, N=3, n=6, RM Two Way ANOVA, treatment p=0.1205, number of pulses 
p<0.001, interaction p=0.0107). In terms of the decay ratios for DHK and TBOA, I did 
not find any significant differences between the decay ratio of DHK and decay ratio of 
TBOA in post hoc test except for the 2 pulses and 5 pulses stimulation. Two-way 
ANOVA revealed an overall significance of treatment (Fig. 23C, E, N=3, n=6, RM Two 
Way ANOVA, treatment p=0.0234, number of pulses p<0.001, interaction p=0.0006).  
Together these data show that GLT-1 plays only a minor role in glutamate clearance and 
that diffusion, particularly during long trains of activity, represents the main method of 
glutamate clearance in the cerebellum.  
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3.3. Effect of glutamate dynamic on ambient glutamate level 
Glutamate transporters are responsible for the rapid removal of synaptically 
released glutamate from the extracellular space but also work to keep ambient levels of 
extracellular glutamate low in the absence of substantial neural activity. By maintaining 
the ambient concentration of extracellular glutamate low, glutamate transporters ensure a 
high signal-to-noise ratio during synaptic neurotransmission (Danbolt 2001). Therefore, I 
asked whether transporter inhibition affects ambient glutamate levels (as measured by 
raw, unstimulated iGluSnFR fluorescence; (Parsons et al., 2016)) differently in the 
hippocampus, cortex, striatum and cerebellum. Experiments were performed in the 
presence of D-APV (50 µM) and DNQX (20 µM). Interestingly, DHK (300 µM) had very 
little effect on basal iGluSnFR values in all four regions (Fig. 24), suggesting that any rise 
in ambient glutamate induced by GLT-1 inhibition is too low to be detected by iGluSnFR. 
However, when TBOA was applied, clear elevations in basal iGluSnFR fluorescence 
were detected in the cortex and striatum (Fig. 24B, C; ANOVA, p<0.001, and post hoc 
Dunnett’s test of control vs TBOA, p< 0.001, for both the cortex and striatum), whereas 
the elevation observed in the hippocampus was modest in comparison (Fig. 24A; 
ANOVA, p =0.027, and post hoc Dunnett’s test of control vs TBOA, p >0.05) and no 
elevation of basal iGluSnFR was observed in cerebellum (Fig. 24 D, ANOVA, p>0.05, 
post hoc Dunnett’s test of control vs TBOA, p>0.05). Thus, similar to the clearance of 
evoked glutamate transients, non-GLT-1 transporters play a substantial role in the 
maintenance of low ambient levels of extracellular glutamate. 
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Chapter 4: Discussion 
The time course of synaptically-released extracellular glutamate is shaped by 
transporter mediated uptake and the morphological properties of the extracellular space 
proximal to the release site (Danbolt 2001; Thomas, Tian, & Diamond 2011). It is 
important to understand how extracellular glutamate is regulated in the CNS, as excess 
extracellular glutamate can impair synaptic plasticity (Li et al., 2011) and promote 
excitotoxicity (Hardingham & Bading, 2010; Parsons & Raymond, 2014). It also has been 
implicated that deficits in GLT-1-mediated uptake and the subsequent pathological 
accumulation of extracellular glutamate can be associated with numerous conditions of 
the CNS including Alzheimer disease, Huntington disease and Amyotrophic Lateral 
Sclerosis (Behrens, Franz, Woodman, Lindenberg, & Landwehrmeyer, 2002; Howland et 
al., 2002; Huang et al., 2010; Liévens et al., 2001; Masliah, Alford, R, Mallory, & 
Hansen, 1996; Miller et al., 2008; Rothstein 1995; Scott, Gebhardt, Mitrovic, 
Vandenberg, & Dodd, 2011). Here, I used widefield iGluSnFR imaging (Armbruster et 
al., 2016; Marvin et al., 2013; Parsons et al., 2016; Pinky, Wilkie, Barnes, & Parsons, 
2018) to characterize the real-time extracellular profiles of synaptically-released 
glutamate in various brain regions and in response to a wide range of synaptic 
stimulation. 
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4.1 Regional differences in glutamate clearance 
By quantifying the decay kinetics of STCs in acute hippocampal slices, it was 
previously demonstrated that glutamate transporters are not overwhelmed by stimulus 
trains up to 10 pulses at 100 Hz (Diamond & Jahr 2000). I demonstrate a similar 
efficiency here in the hippocampus using iGluSnFR, but show that this efficiency is not 
observed in the cortex, striatum and cerebellum (Fig 15). In the cortex and striatum, 
increasing the number of pulses in the stimulus burst from 2 to 10 (100 Hz) increased the 
glutamate clearance time as shown by increasing decay tau suggesting that transporters in 
these regions become overwhelmed earlier than those in the hippocampus. Whereas in the 
cerebellum, the decay tau increased substantially more than that was observed in 
hippocampus, cortex and striatum. Furthermore, iGluSnFR decay rates were consistently 
faster in the hippocampus than in the cortex, striatum and cerebellum regardless of the 
amount of presynaptic activity (Fig 15), consistent with a recent observation of STCs at 
postnatal day 14, where cortical STC decay tau values were approximately two-fold 
slower than the same values in the hippocampus (Hanson et al., 2015). Interestingly, a 
recent study elegantly demonstrated using serial electron microscopy that the distance 
between astrocytes and the postsynaptic density is shorter in the hippocampus compared 
to the striatum (Chai et al., 2017), which may account for the enhanced efficiency of 
transporter mediated uptake in the hippocampus. In addition, prior integrative optical 
imaging and real-time iontophoresis experiments demonstrated that diffusion rates are 
faster in the hippocampus compared to the cortex (Hrabětová, 2005). It was also shown 
previously in cultures that the rate of glutamate uptake is slower in the cerebellum than 
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the cortex and striatum (Drejer, Larsson, & Schousboe, 1982) and I also observed the 
slowest glutamate clearance rates in the cerebellum in my experiments. 
 
In the present study, relative diffusion rates of synaptically-released glutamate 
were quantified by monitoring iGluSnFR decay tau while blocking transporter-mediated 
uptake with 100 μM TBOA, and I found faster diffusion rates in the cerebellum compared 
to hippocampus, cortex and striatum, regardless of the amount of presynaptic activity, 
with a significant difference in cerebellum diffusion rate from cortex and striatum in 
lower pulses (Fig 16). It has been shown before that the glutamate transients received at 
cerebellar Bergmann glia is less than the glutamate transients at the extra-synaptic space 
and it remains elevated in the extra-synaptic space for many milliseconds (Bergles & Jahr 
1997), which indicates the role of diffusion in cerebellum for glutamate clearance from a 
synaptic site. This suggests that the role of diffusion may be more important than 
transporter mediated uptake in the cerebellum. Among the non GLT-1 transporters, 
GLAST (in Bergmann glia) and EAAT4 (Purkinje cell membrane), the role of GLAST 
includes removing the neurotransmitter at early times just after glutamate is being 
released and EAAT4 removes glutamate at a later time point to prevent spillover to the 
neighbouring synapses (Takayasu et al., 2005). It has been illustrated that GLAST 
knockout had no effect on parallel fiber EPSC (Watase et al., 1998) and the role of glial 
glutamate transporters in cerebellum is to prevent the synaptic cross talk (Marcaggi, 
Billups, & Attwell, 2003), suggesting that diffusion mediates a substantial portion of 
glutamate clearance in the cerebellum, with uptake mechanisms acting largely as a 
backup to prevent synaptic crosstalk. It also has been demonstrated previously that, in 
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cerebellum, multi-vesicular release of glutamate can overwhelm nearby transporters 
(Foster, Kreitzer, & Regehr, 2002; Jacques I. Wadiche & Jahr, 2001), hence it is 
important for glutamate to diffuse from the synaptic cleft and then the cerebellar 
glutamate transporters could reduce the glutamate concentration from the extracellular 
space. Together, these data demonstrate clear regional- and activity-dependent differences 
in the rate of glutamate clearance with the efficient transporter mediated uptake in 
hippocampus and the very little role of transporter mediated uptake in cerebellum. 
A recent study used both iGluSnFR and STC recordings to demonstrate that 
presynaptic activity influences glutamate clearance in the cortex (Armbruster et al., 
2016). Here, I also observed a clear effect of presynaptic activity on the rate of glutamate 
clearance, with all tested regions showing a dramatic increase in the time required to clear 
extracellular glutamate following longer HFS trains of 50-100 pulses compared to shorter 
bursts of activity. As glutamate uptake is voltage dependent (Brew & Attwell, 1987), 
astrocyte depolarization during neural activity (Meeks & Mennerick, 2007) may account 
for the slow clearance rates observed following long stimulus trains. Furthermore, neural 
activity induces glial swelling and reduces the extracellular volume fraction, which can 
increase tortuosity and slow glutamate diffusion during long stimulus trains (Syková et 
al., 2008; Sykova, Vargova, Prokopova, & Simonova, 1999). 
As mentioned earlier, I used both shorter (2,5,10 pulses) and longer (50, 100 
pulses) trains of HFS. It was noticed that the profile of iGluSnFR during the long 
stimulation protocols shows a decay phase during the stimulation, which likely represents 
a combination of transmitter depletion and ongoing uptake/diffusion. This feature was 
noticed in hippocampus, cortex, striatum and cerebellum. My study focused on glutamate 
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clearance at the termination of neural activity. It is of the future interest to the lab to 
understand what processes are involved in shaping the iGluSnFR response during 
prolonged stimuli.  
 
 
4.2 Effects of transporter inhibition on iGluSnFR responses 
            For the past two decades, it has been widely-reported that GLT-1 is responsible 
for the large majority of glutamate uptake in the brain, with percentages of 90% or higher 
often being cited in manuscript introductions and review articles. In my study, I found 
that while blocking GLT-1 with 300 μM DHK indeed prolonged the time course of 
evoked iGluSnFR transients, it produced only a fraction of the effect observed following 
100 μM TBOA application. Interestingly, approximately half of the STC persists 
following a saturating concentration of DHK (Diamond & Jahr 2000; Thomas et al. 
2011), which is likely to represent current through GLAST transporters which are also 
abundant on astrocyte membranes (Danbolt 2001). My data here strongly suggest that 
while GLT-1 may be the most abundant transporter in the brain, non-GLT-1 transporters 
can make large contributions to the rate glutamate clearance, particularly when GLT-1 is 
dysfunctional. 
iGluSnFR also represents a powerful tool to study relative alterations in evoked 
presynaptic glutamate release. In the hippocampus, transporter inhibition by either DHK 
or TBOA increased the response peak over two-fold, indicating a facilitation of 
presynaptic release induced by transporter inhibition, in agreement with a previously 
reported increase in excitatory postsynaptic current (EPSC) amplitude following 
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transporter inhibition in the adult hippocampus (Diamond 2005). On the other hand, while 
DHK tended to increase response peaks in the cortex and striatum, response sizes were 
reduced in these regions following TBOA application, also in agreement with a prior 
observation of a TBOA-induced reduction of striatal EPSCs (Milnerwood et al., 2010). 
Transporter inhibition in the hypothalamus increases extracellular glutamate and reduces 
presynaptic release by activating presynaptic group III metabotropic glutamate receptors 
(Oliet, 2001). Here, TBOA had the greatest effect on ambient glutamate levels in the 
striatum and cortex, the two regions that exhibited a TBOA-induced depression of evoked 
glutamate release. Indeed, presynaptic mGluR activation has been shown to inhibit 
excitatory transmission at the corticostriatal synapse (Pisani, Calabresi, Centonze, & 
Bernardi, 1997) and in the deep layers of the cortex (Bandrowski, 2002). Thus, my results 
are consistent with electrophysiological observations of transporter inhibitor effects on 
EPSCs, and suggest that iGluSnFR can be used as a powerful tool to study glutamate 
transmission, both with respect to relative changes in release probability and extracellular 
clearance rates. 
 
4.3 Quantifying glutamate clearance in situ: methodological considerations 
STCs have been used to great effect to study glutamate dynamics in situ, and 
provides the greatest temporal resolution of the available methods, particularly when the 
filtering properties are mathematically eliminated from the STC kinetics (Diamond 2005). 
However, STCs are only able to sense glutamate at the surface of an individual astrocyte, 
are technically demanding and are extremely difficult to elicit in brain regions that have a 
low to moderate density of glutamate afferents. Widefield imaging of iGluSnFR 
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complements STCs in that they monitor extracellular glutamate sensed at the surface of a 
population of neurons (synapsin promoter) or astrocytes (GFAP promoter) and can be 
easily performed in multiple brain regions. However, iGluSnFR itself acts as a glutamate 
buffer and therefore exhibits slower absolute decay tau values compared to STCs under 
similar conditions.  iGluSnFR affinity is in the µM range, and the values that I obtained 
from my present study as “%ΔF/F” match the values obtained by exogenous applications 
of μM concentrations of glutamate in the acute slice preparation (Parsons et al., 2016). 
This suggests that the slower iGluSnFR kinetics likely does not reflect the detection of 
very low glutamate concentrations which can not be detected by the STC  Nonetheless, 
iGluSnFR’s kinetics are sufficiently rapid to clearly resolve subtle relative differences in 
uptake capacity (Armbruster et al., 2016; Parsons et al., 2016). 
 
               4.4 Conclusion 
              The results of the present study demonstrate clear regional- and activity-
dependent differences in the rate of glutamate clearance following synaptic activity and 
further highlight the importance of studying glutamate regulation in situ. The two major 
findings of the present study are as follows: 1) the hippocampus is more efficient at 
clearing extracellular glutamate compared to the cortex, striatum and cerebellum; and 2) 
GLT-1 inhibition by DHK only slowed clearance rates to a fraction of that induced by 
TBOA, suggesting non-GLT-1 transporters can make a substantial contribution to the 
glutamate clearance rate, particularly when GLT-1 is dysfunctional in hippocampus, 
striatum, cortex and cerebellum. The relative efficiency of glutamate clearance may play 
a role in dictating the type and magnitude of synaptic plasticity observed following long 
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trains of HFS. For example, the same HFS that produces clear long-term potentiation in 
the hippocampus results in presynaptically mediated long-term depression in the striatum. 
It is possible that the efficient uptake/clearance of glutamate in the hippocampus limits 
perisynaptic/extrasynaptic mGluR activity, which is required for HFS-induced striatal 
long-term depression (Sung, Choi, & Lovinger, 2001). Furthermore, slow clearance rates 
may play a role in regional vulnerability to excitotoxity. It is tempting to speculate that 
the slow clearance rates in the striatum can partially explain this region’s vulnerability in 
Huntington disease, a devastating neurodegenerative disease in which glutamate toxicity 
and extrasynaptic NMDA receptor activation are major contributors to cell death 
(Milnerwood et al., 2010; Okamoto et al., 2009; Parsons & Raymond, 2014). Future 
research is required to fully understand the functional consequences of such dramatic 
regional differences in glutamate clearance, as the spatiotemporal dynamics of glutamate 
ultimately determines the location and types of glutamate receptors that are activated 
during neurotransmission. 
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                                                       Figures 
 
Figure 1: Adapted from (Tzingounis & Wadiche, 2007), showing the mechanism of 
action of glutamate transport across the cell membrane. 
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Figure 2: A diagram of hippocampal circuitry showing the Schaffer collateral pathway 
and mossy fiber pathway. The figure also shows the following areas in the hippocampus: 
Dentate gyrus (DG), CA3 and CA1. 
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Figure 3: Characterization of extracellular glutamate dynamics in the hippocampus. A, 
Representative heatmaps of iGluSnFR responses after afferent stimulation (100 Hz). Peak 
responses are shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show 
the kinetics of the response at a defined x-coordinate adjacent to the site of stimulation 
(image represents 2 s). The gray shaded area within the images denotes the onset and 
duration of afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 2, 5, 10, 
50, or 100 pulses of afferent stimulation at 100 Hz. C, Mean responses (±SEM) 
From B that were normalized to the peak value at the end of the stimulation. 
D–E, Grouped data showing mean (±SEM) iGluSnFR response peak (D) and decay tau 
(E). RM ANOVA with Tukey’s post hoc results are indicated by *p<0.05 and 
***p<0.001. 
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Figure 4: Relationship between iGluSnFR response peak and decay kinetics in the 
hippocampus. A-B, Decay and Peak (%ΔF/F) correlation of the iGluSnFR responses with 
a short burst of activity (A) and longer trains of high frequency stimulation (B). 
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Figure 5: Effect of stimulus intensity on extracellular glutamate dynamics in the 
hippocampus. A, Mean (±SEM) iGluSnFR response profiles in response to increasing the 
stimulus intensity (5 pulses, 100 Hz) from 25 to 250 µA. B-C, Grouped data showing 
mean (±SEM) iGluSnFR response peak (B) and decay tau (C) in response to increasing 
the stimulus intensity (5 pulses, 100 Hz) from 25 to 250 µA. RM ANOVA for (B, C) 
showed ***p<0.001. 
D, Comparison of the effect of stimulus intensity on iGluSnFR peak and decay tau for the 
hippocampus, Data were normalized to the response at 25 µA. All p values were obtained 
by two-way RM ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
 
 
 
54 
 
 
Figure 6: Characterization of extracellular glutamate dynamics in the cortex. A, 
Representative heatmaps of iGluSnFR responses after afferent stimulation (100 Hz). Peak 
responses are shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show 
the kinetics of the response at a defined x-coordinate adjacent to the site of stimulation 
(image represents 2 s). The gray shaded area within the images denotes the onset and 
duration of afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 2, 5, 10, 
50, or 100 pulses of afferent stimulation at 100 Hz. C, Mean responses (±SEM) 
From B that were normalized to the peak value at the end of the stimulation. 
D–E, Grouped data showing mean (±SEM) iGluSnFR response peak (D) and decay tau 
(E). RM ANOVA with Tukey’s post hoc results are indicated by *p<0.05,**p<0.01 and 
***p<0.001. 
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Figure 7: Relationship between iGluSnFR response peak and decay kinetics in the cortex. 
A-B, Decay and Peak (%ΔF/F) correlation of the iGluSnFR responses with a short burst 
of activity (A) and longer trains of high frequency stimulation (B). 
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Figure 8: Effect of stimulus intensity on extracellular glutamate dynamics in the cortex. 
A, Mean (±SEM) iGluSnFR response profiles in response to increasing the stimulus 
intensity (5 pulses, 100 Hz) from 25 to 250 µA. B-C, Grouped data showing mean 
(±SEM) iGluSnFR response peak (B) and decay tau (C) in response to increasing the 
stimulus intensity (5 pulses, 100 Hz) from 25 to 250 µA. RM ANOVA for (B, C) showed 
***p<0.001. 
D, Comparison of the effect of stimulus intensity on iGluSnFR peak and decay tau for the 
cortex, Data were normalized to the response at 25 µA. All p values were obtained by 
two-way RM ANOVA. 
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Figure 9: Characterization of extracellular glutamate dynamics in the striatum. A, 
Representative heatmaps of iGluSnFR responses after afferent stimulation (100 Hz). Peak 
responses are shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show 
the kinetics of the response at a defined x-coordinate adjacent to the site of stimulation 
(image represents 2 s). The gray shaded area within the images denotes the onset and 
duration of afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 2, 5, 10, 
50, or 100 pulses of afferent stimulation at 100 Hz. C, Mean responses (±SEM) 
From B that were normalized to the peak value at the end of the stimulation. 
D–E, Grouped data showing mean (±SEM) iGluSnFR response peak (D) and decay tau 
(E). RM ANOVA with Tukey’s post hoc results are indicated by **p<0.01 and 
***p<0.001. 
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Figure 10: Relationship between iGluSnFR response peak and decay kinetics in the 
striatum. A-B, Decay and Peak (%ΔF/F) correlation of the iGluSnFR responses with a 
short burst of activity (A) and longer trains of high frequency stimulation (B). 
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Figure 11: Effect of stimulus intensity on extracellular glutamate dynamics in the 
striatum. A, Mean (±SEM) iGluSnFR response profiles in response to increasing the 
stimulus intensity (5 pulses, 100 Hz) from 25 to 250 µA. B-C, Grouped data showing 
mean (±SEM) iGluSnFR response peak (B) and decay tau (C) in response to increasing 
the stimulus intensity (5 pulses, 100 Hz) from 25 to 250 µA. RM ANOVA for (B, C) 
showed ***p<0.001 (B) and **p<0.01 (C) 
D, Comparison of the effect of stimulus intensity on iGluSnFR peak and decay tau for the 
striatum, Data were normalized to the response at 25 µA. All p values were obtained by 
two-way RM ANOVA. 
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Figure 12: Characterization of extracellular glutamate dynamics in the cerebellum. A, 
Representative heatmaps of iGluSnFR responses after afferent stimulation (100 Hz). Peak 
responses are shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show 
the kinetics of the response at a defined x-coordinate adjacent to the site of stimulation 
(image represents 2 s). The gray shaded area within the images denotes the onset and 
duration of afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 2, 5, 10, 
50, or 100 pulses of afferent stimulation at 100 Hz. C, Mean responses (±SEM) 
From B that were normalized to the peak value at the end of the stimulation. 
D–E, Grouped data showing mean (±SEM) iGluSnFR response peak (D) and decay tau 
(E). RM ANOVA with Tukey’s post hoc results are indicated by *p<0.05, **p<0.01 and 
***p<0.001. 
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Figure 13: Relationship between iGluSnFR response peak and decay kinetics in the 
cerebellum. A-B, Decay and Peak (%ΔF/F) correlation of the iGluSnFR responses with a 
short burst of activity (A) and longer trains of high frequency stimulation (B). 
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Figure 14: (A) Regional differences in glutamate clearance capacity. A, Representative 
heatmaps of iGluSnFR responses in the hippocampus, cortex, striatum and cerebellum 
after afferent stimulation (10 pulses at 100 Hz). Peak responses are shown in the x–y 
plane (image size, 2*2 mm), and the y–z (time) plots show the kinetics of the response at 
a defined x-coordinate adjacent to the site of stimulation (image represents 2 s). The gray 
shaded area within the images denotes the onset and duration of afferent stimulation. B, 
Mean (±SEM) iGluSnFR responses in the hippocampus, cortex, striatum and cerebellum 
to 10 pulses at 100 Hz. C, Mean responses (±SEM) from B that were normalized to the 
peak value at the end of the stimulation. 
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Figure 15: Regional differences in glutamate clearance capacity showed by iGluSnFr 
decay kinetics in hippocampus, cortex, striatum and cerebellum. (A, B), Regional 
comparison of mean (±SEM) iGluSnFR decay tau values showing fastest glutamate 
clearance rates in the hippocampus, for both shorter bursts of 
activity (A) and longer trains of high-frequency stimulation (B). Two way ANOVA with 
Bonferroni post hoc test, *p<0.05 and ***p<0.001. 
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Figure 16: Regional differences in glutamate clearance capacity showed by iGluSnFr 
decay kinetics in hippocampus, cortex, striatum and cerebellum during glutamate 
transporter blockade with TBOA (100 µM) to quantify relative glutamate diffusion rates. 
(A, B), Regional comparison of mean (±SEM) iGluSnFR decay tau values showing 
fastest glutamate clearance rates in the cerebellum after TBOA (100 µM), for both shorter 
bursts of 
activity (A) and longer trains of high-frequency stimulation (B). Two way ANOVA with 
Bonferroni post hoc test, *p<0.05, **p<0.01 and ***p<0.001 
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Figure 17: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the hippocampus. A, Representative 
heatmaps of hippocampal iGluSnFR responses after afferent stimulation (10 pulses at 100 
Hz) in control conditions and after GLT-1 blockade with DHK (300 µM) and 
nonselective glutamate transporter blockade with TBOA (100 µM). Peak responses are 
shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show the kinetics 
of the response at a defined x-coordinate adjacent to the site of stimulation 
(image represents 2 s). The gray shaded area within the images denotes the onset and 
duration of afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 10 
pulses of afferent stimulation at 100 Hz in control, DHK, and TBOA conditions. C, Mean 
responses (±SEM) from B that were normalized to the peak value at the end of the 
stimulation. D–E, Grouped data showing mean (±SEM) DHK and TBOA peak ratios (D) 
and decay ratios (E) over a variety of stimulation paradigms. Peak and decay ratios 
indicate the fold effect of drug treatment over control levels. Two-way RM ANOVA with 
Bonferroni’s post hoc results are indicated by ***p <0.001. 
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Figure 18: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the hippocampus. Grouped data showing 
mean (± SEM) DHK and TBOA peak ratios (A) and decay ratios (B) in hippocampus 
over a variety of stimulation paradigms while applying 300 µM DHK and 10 µM TBOA. 
Two way ANOVA showed non-significant treatment effect between 300 µM DHK and 
10 µM TBOA. 
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Figure 19: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the cortex. A, Representative heatmaps of 
cortex iGluSnFR responses after afferent stimulation (10 pulses at 100 Hz) in control 
conditions and after GLT-1 blockade with DHK (300 µM) and nonselective glutamate 
transporter blockade with TBOA (100 µM). Peak responses are shown in the x–y plane 
(image size, 2*2 mm), and the y–z (time) plots show the kinetics of the response at a 
defined x-coordinate adjacent to the site of stimulation (image represents 2 s). The gray 
shaded area within the images denotes the onset and duration of afferent stimulation. B, 
Mean (±SEM) iGluSnFR response profiles to 10 pulses of afferent stimulation at 100 Hz 
in control, DHK, and TBOA conditions. C, Mean responses (±SEM) from B that were 
normalized to the peak value at the end of the stimulation. D–E, Grouped data showing 
mean (±SEM) DHK and TBOA peak ratios (D) and decay ratios (E) over a variety of 
stimulation paradigms. Peak and decay ratios indicate the fold effect of drug treatment 
over control levels. Two-way RM ANOVA with Bonferroni’s post hoc results are 
indicated by *p <0.05, **p <0.01 and ***p <0.001. 
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Figure 20: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the cortex. Grouped data showing mean 
(± SEM) DHK and TBOA peak ratios (A) and decay ratios (B) in cortex over a variety of 
stimulation paradigms while applying 300 µM DHK and 10 µM TBOA. Two way 
ANOVA showed non-significant treatment effect between 300 µM DHK and 10 µM 
TBOA. 
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Figure 21: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the striatum. A, Representative heatmaps 
of striatum iGluSnFR responses after afferent stimulation (10 pulses at 100 Hz) in control 
conditions and after GLT-1 blockade with DHK (300 µM) and nonselective glutamate 
transporter blockade with TBOA (100 µM). Peak responses are shown in the x–y plane 
(image size, 2*2 mm), and the y–z (time) plots show the kinetics of the response at a 
defined x-coordinate adjacent to the site of stimulation (image represents 2 s). The gray 
shaded area within the images denotes the onset and duration of afferent stimulation. B, 
Mean (±SEM) iGluSnFR response profiles to 10 pulses of afferent stimulation at 100 Hz 
in control, DHK, and TBOA conditions. C, Mean responses (±SEM) from B that were 
normalized to the peak value at the end of the stimulation. D–E, Grouped data showing 
mean (±SEM) DHK and TBOA peak ratios (D) and decay ratios (E) over a variety of 
stimulation paradigms. Peak and decay ratios indicate the fold effect of drug treatment 
over control levels. Two-way RM ANOVA with Bonferroni’s post hoc results are 
indicated by **p <0.01 and ***p <0.001. 
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Figure 22: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the striatum. Grouped data showing mean 
(± SEM) DHK and TBOA peak ratios (A) and decay ratios (B) in cortex over a variety of 
stimulation paradigms while applying 300 µM DHK and 10 µM TBOA. Two way 
ANOVA showed non-significant treatment effect between 300 µM DHK and 10 µM 
TBOA. 
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Figure 23: Comparison of the effects of selective GLT-1 inhibition and nonselective 
transporter inhibition on glutamate dynamics in the cerebellum. A, Representative 
heatmaps of cerebellum iGluSnFR responses after afferent stimulation (10 pulses at 100 
Hz) in control conditions and after GLT-1 blockade with DHK (300 µM) and 
nonselective glutamate transporter blockade with TBOA (100 µM). Peak responses are 
shown in the x–y plane (image size, 2*2 mm), and the y–z (time) plots show the kinetics 
of the response at a defined x-coordinate adjacent to the site of stimulation (image 
represents 2 s). The gray shaded area within the images denotes the onset and duration of 
afferent stimulation. B, Mean (±SEM) iGluSnFR response profiles to 10 pulses of 
afferent stimulation at 100 Hz in control, DHK, and TBOA conditions. C, Mean 
responses (±SEM) from B that were normalized to the peak value at the end of the 
stimulation. D–E, Grouped data showing mean (±SEM) DHK and TBOA peak ratios (D) 
and decay ratios (E) over a variety of stimulation paradigms. Peak and decay ratios 
indicate the fold effect of drug treatment over control levels. Two-way RM ANOVA with 
Bonferroni’s post hoc results are indicated by **p <0.01. 
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Figure 24: Ambient glutamate levels after the application of DHK and TBOA. A–D, 
Basal, unstimulated iGluSnFR fluorescence in control conditions and after GLT-1 
inhibition with 300 µM DHK and nonselective glutamate transporter inhibition with 100 
µM TBOA in the hippocampus (A), cortex (B), striatum (C) and cerebellum (D). One-
way RM ANOVA significance was observed for hippocampus, cortex and striatum. 
Dunnett’s test post hoc significance is indicated by **p <0.01.  
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APPENDIX
 
Figure A1: GLT-1 expression levels are similar in the adult hippocampus, cortex, 
striatum and cerebellum (Pinky et al., 2018). A, Representative Western blot of GLT-1 
expression in the cortex (Ctx), hippocampus (Hpc), striatum (Str) and cerebellum (Cereb). 
B, Quantification of mean (±SEM) GLT-1 expression in the cortex (C), hippocampus (H), 
striatum (S) and cerebellum (Cr). ANOVA, p=0.819. 
 
